Paper · 38448564
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 37
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36992136 | Impact of MERS-CoV and SARS-CoV-2 Viral Infection on Immunoglobulin-IgG Cross-Reactivity. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/36992136 | PubMed |
| 2 | 26473733 | Serological Evidence of MERS-CoV Antibodies in Dromedary Camels (Camelus dromedaries) in Laikipia County, Kenya. | PLoS One | 2015 | https://conductscience.org/library/papers/26473733 | PubMed |
| 3 | 35076258 | Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants. | Sci Immunol | 2022 | https://conductscience.org/library/papers/35076258 | PubMed |
| 4 | 37090738 | Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status. | Front Immunol | 2023 | https://conductscience.org/library/papers/37090738 | PubMed |
| 5 | 36727646 | Treatment with integrase inhibitors alters SARS-CoV-2 neutralization levels measured with HIV-based pseudotypes in people living with HIV. | J Med Virol | 2023 | https://conductscience.org/library/papers/36727646 | PubMed |
| 6 | 34812143 | Cross-reactive antibodies after SARS-CoV-2 infection and vaccination. | Elife | 2021 | https://conductscience.org/library/papers/34812143 | PubMed |
| 7 | 34716096 | Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel. | Semin Immunol | 2021 | https://conductscience.org/library/papers/34716096 | PubMed |
| 8 | 35196424 | Population Immunity and Covid-19 Severity with Omicron Variant in South Africa. | N Engl J Med | 2022 | https://conductscience.org/library/papers/35196424 | PubMed |
| 9 | 32427175 | Bat-borne viruses in Africa: a critical review. | J Zool (1987) | 2020 | https://conductscience.org/library/papers/32427175 | PubMed |
| 10 | 32410735 | Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism. | Biochem Biophys Res Commun | 2020 | https://conductscience.org/library/papers/32410735 | PubMed |
| 11 | 37768085 | Relative resistance of patient-derived envelope sequences to SERINC5-mediated restriction of HIV-1 infectivity. | J Virol | 2023 | https://conductscience.org/library/papers/37768085 | PubMed |
| 12 | 30570714 | Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya. | Virol Sin | 2018 | https://conductscience.org/library/papers/30570714 | PubMed |
| 13 | 1660837 | Efficient selection for high-expression transfectants with a novel eukaryotic vector. | Gene | 1991 | https://conductscience.org/library/papers/1660837 | PubMed |
| 14 | 26138557 | Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein. | Arch Virol | 2015 | https://conductscience.org/library/papers/26138557 | PubMed |
| 15 | 37310218 | Evaluation of Neutralizing Activity against Omicron Subvariants in BA.5 Breakthrough Infection and Three-Dose Vaccination Using a Novel Chemiluminescence-Based, Virus-Mediated Cytopathic Assay. | Microbiol Spectr | 2023 | https://conductscience.org/library/papers/37310218 | PubMed |
| 16 | 33270134 | Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/33270134 | PubMed |
| 17 | 36214577 | Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike. | J Virol | 2022 | https://conductscience.org/library/papers/36214577 | PubMed |
| 18 | 23994189 | Receptor recognition and cross-species infections of SARS coronavirus. | Antiviral Res | 2013 | https://conductscience.org/library/papers/23994189 | PubMed |
| 19 | 35902675 | Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic. | Sci Rep | 2022 | https://conductscience.org/library/papers/35902675 | PubMed |
| 20 | 34623973 | Cross-protective immunity following coronavirus vaccination and coronavirus infection. | J Clin Invest | 2021 | https://conductscience.org/library/papers/34623973 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/38448564/references